β-cyclodextrin reduces bioavailability of orally administered [ 3H]benzo[a]pyrene in the rat

Journal of Pharmaceutical Sciences

Volumn 94, Issue 1, 2005, Pages 114-119

  Westerberg, Goran ^a   Wiklund, Lars ^a,b  

^a PFIZER INC   (United States)

^b RegSafe (Regulatory Safety Sciences)   (Sweden)

Author keywords

Absorption; Benzo a pyrene; Bioavailability; Carcinogens; Cyclodextrins; Gastrointestinal; Pharmacokinetics

Indexed keywords

BENZO[A]PYRENE; BETA CYCLODEXTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG HALF LIFE; FECES; FEMALE; MALE; NONHUMAN; RADIOACTIVITY; RAT; SINGLE DRUG DOSE;

EID: 12244310168     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20198     Document Type: Article

References (16)

1. Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins 1, Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
2. Loftsson T, Masson M, Brewster ME. 2004. Self-association of cyclodextrins and cyclodextrin complexes. J Pharm Sci 93:1091-1099.
3. JECFA Working Group. 1996. β-Cyclodextrin, Toxicological evaluation of certain food additives and contaminants. In: WHO food additives series 35. Geneva: WHO. pp 257-268.
4. Rowe R, Sheskey PJ, Weller PJ, editors. 2003. Cyclodextrins. In: Handbook of pharmaceutical excipients, 4th ed. London: Pharmaceutical Press, pp 186-190.
5. Irei T, Uekama K. 1997. Pharmaceutical applications of cyclodextrins III. Toxicological issues and safety evaluation. J Pharm Sci 86:147-162.
6. Thompson DO. 1997. Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. In: Therapeutic drug carrier systems 14. Boca Raton, FL: CRC Press, pp 1-104.
7. JECFA Working Group. 1993. β-Cyclodextrin, toxicological evaluation of certain food additives and contaminants. In: WHO food additive series 32. Geneva: WHO. pp 173-193.
8. Parfitt K. 1999. Cyclodextrins-The complete drug reference, 32nd ed. London: Martindale Pharmaceutical Press.
9. Horsky J, Pitha J. 1996. Hydroxypropyl cyclodextrins: Potential synergism with carcinogens. J Pharm Sci 85:96-100.
10. Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J. 1997. Tobacco products. In: Ellenhorn's medical toxicology, diagnosis and treatment of human poisoning, 2nd ed. London: Williams & Wilkins. pp 1110-1121.
11. Bouchard M, Viau C. 1996. Urinary excretion kinetics of pyrene and benzo[a]pyrene metabolites following intravenous administration of the parent compounds or the metabolites. Toxicol Appl Pharmacol 139:301-309.
12. Foth H, Kahl R, Kahl GF. 1988. Pharmacokinetics of low doses of benzo[a]pyrene in the rat. Food Chem Toxicol 26:45-51.
13. Moir D, Viau A, Chu I, Withey J, McMullen E. 1998. Pharmacokinetics of benzo[a]pyrene in the rat. J Toxicol Environ Health 53:507-530.
14. Weyand EH, Beven DR. 1987. Species differences in disposition of benzo[a]pyrene. Drug Met Dispos 15:442-448.
15. 14C-β-cyclodextrin in the rat. Arzneimittelforsch/Drug Res 35:1042-1047.
16. Antenucci RN, Palmer JK. 1984. Enzymatic degradation of α- and β-cyclodextrins by Bacteroides of the human colon. J Agric Food Chem 32:1316-1321.